Federal Register Notice: FDA’s Advisory Committee for Reproductive Health Drugs will meet 8/29, from 8 a.m. to 5:30 p.m. at the Hilton Hotel, The Ballrooms, 620 Perry Pkwy., Gaithersburg, MD. The committee will discuss Adeza Biomedical’s NDA for Gestiva, 17 alpha-hydroxyprogesterone caproate injection, 250 mg/mL, for preventing pre-term delivery in women with a history of a prior pre-term delivery. Contact Teresa Watkins, (301) 827-7001. To view this notice, click here.